Event Overview:
The Japan pharmaceutical market remains a strategic market for investment for many companies, but performance in the last few years has been challenging for some and rewarding for others. While growth dynamics are varied - with strong growth in specialty related therapy areas, biologics, new product innovation, and elderly-related therapy areas to name a few - pharmaceutical companies look to understand these trends as they shift focus to gain access to these and other strategic opportunities. On top of this growth is added pressure on healthcare spend and funding and related MHLW policy changes and initiatives in recent years to manage spend and establish a new direction for the market. Join the ACCJ and the EBC as we discuss these and other issues impacting the market today and in the coming years. If you are in the healthcare industry, this event is a must. Alan Thomas joined IMS Japan in 1999 and has held various roles during his time with the organization including marketing, sales and account management, and client relations. In 2016, Alan was appointed to his current role as Director, Thought Leadership at the newly established QuintilesIMS. NOTE 1: This event is OFF THE RECORD. NOTE 2: If you cancel after the stated deadline, the full meeting fee will be charged to your account. All guests must be accompanied by an ACCJ member. Sorry, no substitutions or walk-ins. NOTE 3: If you are driving to the Tokyo American Club, please inform the ACCJ of the make, model, color and plate of the vehicle, by the registration deadline, as arrangements must be made. A 1,100 yen parking fee will apply. Comments are closed.
|
Proudly powered by Weebly
